Retatrutide is a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By stimulating these receptors, https://anyaiiwf015488.blogpostie.com/57448640/retatrutide-a-promising-new-treatment-for-obesity